← Back to Search

Behavioral Intervention

Mobile Smoking Treatment for Spanish-speaking Latinx Smokers

N/A
Waitlist Available
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1) 18 to 55 year of age, 2) current smoker (i.e., at least 6 cigarettes/day), 3) not currently engaged in smoking cessation treatment, 4), high anxiety sensitivity (AS) score defined as an ASI-III score of ≥ 23, 5) motivation to quit \> 5 on a 10 pt. scale, 6) Spanish speaking, and 7) currently own an Android-compatible mobile phone.
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 2, 4, 6, and 8
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a mobile app called Impacto, which is designed to help Spanish-speakers quit smoking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 2, 4, 6, and 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 2, 4, 6, and 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
7-Day Point Prevalence Smoking Abstinence
Change in Smoking Rate (# cigarettes per day)
Secondary study objectives
Change in Anxiety Sensitivity
Change in Mood and Anxiety Symptoms
Daily Adherence to Use of Impacto Mobile App (Impacto Condition Only)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ImpactoExperimental Treatment1 Intervention
This is the mobile app to be developed and evaluated in this project.
Group II: Dejar de Fumar AsistenteActive Control1 Intervention
This is the mobile app that will serve as the control condition in evaluating the efficacy of Impacto.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
151 Previous Clinical Trials
47,895 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,777 Total Patients Enrolled
~7 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top